Second, although we found that LAIR‐1 expression was interrelated with patient prognosis and immune invasion in glioma, we could not prove that LAIR‐1 affects prognosis through immune invasion, which needs to be verified using different cell lines. The gene discussed is LAIR1; the disease is central nervous system cancer.